Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| FEDERAL MOGU | FDML | 6.78% |
| SUMMER INFAN | SUMR | 6.78% |
| NEW ORIENTAL | EDU | 5.47% |
| NATUS MEDICA | BABY | 5.62% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
A.M. Best Co. has kept the financial strength rating (“FSR”) of A (Excellent) and issuer credit rating (“ICR”) of “a+” of AMEX Assurance Company, an operating subsidiary of American Express Co. ( AXP - Analyst Report ) (“AmEx”). The outlook for all the ratings remains stable.
The rating affirmations came on the back of AMEX Assurance’s solid capital positioning owing to its risk-averse nature towards investing. In addition, operating efficiency manifested by the company in generating income by selling insurance related products to the AmEx cardholders was a contributing factor.
The margin expansion has been brought about by AMEX Assurance’s efficiency in restricting its expenditures at low levels, proper direct marketing strategy and its stress on certain specific insurance policies.
However, there are quite a few factors working against the company. All AMEX Assurance businesses are targeted towards AmEx cardholders, and given the sluggish growth of policyholders’ surplus in the last 5 years there is not much upside for the subsidiary. Also, the company has very little reserve as most of it has been eroded over the years by paying dividends.
There is no clear indication that the ratings agency is contemplating an increase in the current ratings. However, A.M. Best expects AMEX Assurance to sustain its operating profitability and maintain the level of premiums earned as a decline would prompt the rating agency to reduce the ratings.
We believe both the company and its subsidiaries need to focus more on product diversification to improve its earnings and reduce its risk to a certain extent. AmEx’s stocks gained 61 cents (or 1.1%) since the announcement of the news to close at $57.10 yesterday.
AmEx’s closest competitors Mastercard Incorporated ( MA - Analyst Report ) and Visa, Inc. ( V - Analyst Report ) also received rating affirmations from Standard & Poor's Ratings Services (“S&P”), according to Reuters. The rating agency has confirmed the long-term and short-term counterparty credit ratings of 'A-/A-2' on Mastercard with a positive outlook. Concurrently, it also avowed similar rating of 'A+/A-1' on Visa with a stable outlook.
AmEx currently retains a Zacks #3 Rank, which translates into a short-term Hold rating. We also maintain a long-term Neutral recommendation on its stock.
Read the full reports :
Analyst Report on AXP
Analyst Report on MA
Analyst Report on V